Mohammad Omar Faruk Shaikh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 227 | 0.690 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2020 | 272 | 0.660 |
Why?
|
| Anemia, Aplastic | 1 | 2020 | 226 | 0.640 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2020 | 647 | 0.600 |
Why?
|
| Thrombocythemia, Essential | 1 | 2016 | 103 | 0.510 |
Why?
|
| Polycythemia Vera | 1 | 2016 | 163 | 0.490 |
Why?
|
| Primary Myelofibrosis | 1 | 2016 | 214 | 0.470 |
Why?
|
| Graft vs Host Disease | 1 | 2020 | 2951 | 0.310 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 1811 | 0.290 |
Why?
|
| Pakistan | 4 | 2016 | 296 | 0.280 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1515 | 0.250 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2008 | 642 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5425 | 0.210 |
Why?
|
| Handwriting | 1 | 2020 | 28 | 0.190 |
Why?
|
| Piperazines | 1 | 2008 | 2488 | 0.160 |
Why?
|
| Biotechnology | 1 | 2009 | 278 | 0.150 |
Why?
|
| Pyrimidines | 1 | 2008 | 2933 | 0.140 |
Why?
|
| Medical Order Entry Systems | 1 | 2020 | 544 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2009 | 1132 | 0.120 |
Why?
|
| Metaphase | 1 | 2014 | 151 | 0.120 |
Why?
|
| Documentation | 1 | 2020 | 865 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1296 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 1597 | 0.110 |
Why?
|
| Cytogenetic Analysis | 1 | 2014 | 295 | 0.110 |
Why?
|
| Polymers | 1 | 2009 | 1618 | 0.100 |
Why?
|
| Karyotyping | 1 | 2014 | 1243 | 0.100 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 457 | 0.100 |
Why?
|
| Hernia, Inguinal | 1 | 2013 | 202 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 1731 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13655 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77098 | 0.060 |
Why?
|
| Benzamides | 1 | 2008 | 1378 | 0.060 |
Why?
|
| Middle Aged | 6 | 2020 | 213127 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 56350 | 0.050 |
Why?
|
| Adult | 6 | 2020 | 213712 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4554 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2005 | 705 | 0.050 |
Why?
|
| Laparoscopy | 1 | 2013 | 2121 | 0.050 |
Why?
|
| Adolescent | 4 | 2020 | 85649 | 0.050 |
Why?
|
| Clinical Audit | 1 | 2020 | 31 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4664 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2020 | 15244 | 0.050 |
Why?
|
| Starch | 1 | 2009 | 81 | 0.040 |
Why?
|
| Fermentation | 1 | 2009 | 143 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2020 | 40955 | 0.040 |
Why?
|
| Viscosity | 1 | 2009 | 328 | 0.040 |
Why?
|
| Gases | 1 | 2009 | 197 | 0.040 |
Why?
|
| Male | 6 | 2020 | 349538 | 0.040 |
Why?
|
| Crystallization | 1 | 2009 | 525 | 0.040 |
Why?
|
| Plants | 1 | 2009 | 314 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2009 | 594 | 0.040 |
Why?
|
| Polyesters | 1 | 2009 | 363 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 962 | 0.040 |
Why?
|
| Aged | 4 | 2016 | 162944 | 0.040 |
Why?
|
| Female | 5 | 2020 | 379592 | 0.040 |
Why?
|
| Materials Testing | 1 | 2009 | 865 | 0.030 |
Why?
|
| Child | 3 | 2020 | 77478 | 0.030 |
Why?
|
| Humans | 7 | 2020 | 742088 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 29010 | 0.030 |
Why?
|
| Temperature | 1 | 2009 | 2207 | 0.030 |
Why?
|
| Peritoneum | 1 | 2013 | 226 | 0.030 |
Why?
|
| Equipment Design | 1 | 2009 | 3582 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2013 | 53187 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2005 | 571 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8333 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6294 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 7141 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39004 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2005 | 21719 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 62966 | 0.000 |
Why?
|
| Infant | 1 | 2005 | 35070 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 57683 | 0.000 |
Why?
|